Pediatric Sjogren Syndrome Workup
- Author: Eyal Muscal, MD; Chief Editor: Lawrence K Jung, MD more...
Approach Considerations
Diagnosis of primary Sjögren syndrome is made in adults if the serology or histopathology is positive and if 4 of the American-European Consensus Group (AECG) criteria for adult patients are met[20] :
Mandatory criteria are as follows:
- Characteristic histopathologic features on minor salivary gland biopsy findings: In minor salivary glands (obtained through normal-appearing mucosa) focal lymphocytic sialoadenitis, evaluated by an expert histopathologist, with a focus score of greater than 1, defined as a number of lymphocytic foci (that are adjacent to normal-appearing mucous acini and contain >50 lymphocytes) per 4 mm2 of glandular tissue OR
- Serology: Anti-Ro (SS-A) or anti-La (SS-B)
AECG adult criteria are as follows (4 adult criteria needed):
- At least 1 positive response to the ocular symptom questions (see Screening Questions, below)
- At least 1 positive response to the oral symptom questions (see Screening Questions, below)
- Ocular signs - Positive Schirmer tear test or Rose-Bengal stain findings
- Salivary gland involvement revealed by at least 1 testing modality (salivary scintigraphy, parotid sialography, unstimulated salivary flow)
- Exclusion criteria - Preexisting lymphoma, human immunodeficiency virus (HIV), hepatitis C, sarcoidosis, graft versus host disease (GVHD)
Criteria for pediatric patients have been proposed but not prospectively validated.[21] Only 76% sensitivity has been noted in studies of retrospective patients.[18] The clinical judgment of a pediatric rheumatologist is the criterion standard. However, the proposed pediatric criteria appear more sensitive than adult AECG criteria in classifying primary pediatric Sjögren syndrome. Diagnosis is based on the presence of 4 or more of the following proposed pediatric diagnostic criteria:
- Exclusion of all other autoimmune diseases
- Oral symptoms - Dry mouth, parotitis, and parotid gland enlargement
- Ocular symptoms - Recurrent conjunctivitis and keratoconjunctivitis sicca
- Other mucosal symptoms - Recurrent vaginitis or vulvovaginitis
- Systemic symptoms - Fever of unknown origin, noninflammatory arthralgias, and hypokalemic paralysis
- Presence of anti-Ro (SS-A), anti-La (SS-B), high titer ANA, or RF
- Elevated serum amylase levels
- Leukopenia and high erythrocyte sedimentation rate (ESR)
- Polyclonal hyperimmunoglobulinemia
- Renal tubular acidosis[19]
- Histologic proof of lymphocytic infiltration of salivary gland or other organs
- Objective documentation of ocular dryness - Schirmer tear test or Rose Bengal stain findings
- Objective documentation of parotid gland enlargement - Sialography findings
On a complete blood count (CBC) with differential, mild anemia and leukopenia are often present in patients with Sjögren syndrome. Elevated erythrocyte sedimentation rate (ESR) is observed in 80-90% of patients, which may be related to hypergammaglobulinemia; however, C-reactive protein (CRP) levels are usually within the reference range. Hypergammaglobulinemia, up to several grams of immunoglobulin G (IgG), is observed in 70-80% of pediatric and adult patients.
Antibodies
ANA and rheumatoid factor RF levels are usually elevated in children. Anti-Ro (SS-A) and anti-La (SS-B) are also usually present in children.
Various autoantibodies may be found in patients with Sjögren syndrome; however, the clinical or diagnostic implication is often unclear. Autoantibodies include thyroglobulin, thyroid microsomal, mitochondrial, smooth muscle, parietal, peroxisomal, muscarinic receptors, and salivary duct (often present in adults with Sjögren syndrome) autoantibodies. Cryoglobulins and, occasionally, antiphospholipid antibodies are noted.
Keratoconjunctivitis and Tear Production
In Rose Bengal staining, the dye stains damaged corneal epithelium and indicates keratoconjunctivitis. This is not often performed in children.
Schirmer tear test is used to evaluate tear production by lacrimal glands. A strip of filter paper is placed beneath the lower lid, and wetting of the paper is measured at 5 minutes. Less than 10 mm of film is abnormal, and less than 5 mm of wetting suggests decreased tear production and sicca syndrome. This test is performed more often in pediatric patients.
Saliva Production and Sialochemistry
Sialometry is the quantification of whole saliva or individual gland secretions at unstimulated (resting) or stimulated flow rates. These procedures are not commonly used in pediatric patients.
For salivary hypofunction, the flow rate for unstimulated whole saliva is less than 0.1 mL/min, whereas the rate for stimulated whole saliva is less than 0.5 mL/min. The collection period is a minimum of 5 minutes and often up to 15 minutes. When secretions from the parotid gland are evaluated, the modified Carlson-Crittenden collector is placed over the Stensen duct. Isolation of the salivary gland orifices in the floor of the mouth and gentle suction are used to collect submandibular and sublingual secretions together. Besides demonstrating salivary hypofunction, these methods can be used to evaluate the effectiveness of secretogogue therapy.
On sialochemistry, collected secretions can be chilled, frozen, and evaluated for electrolytes, immunoglobulins, and protein constituents. Although not diagnostic for Sjögren syndrome, a profile has been observed, including an increase in secretory levels of immunoglobulin A, lactoferrin, total protein, and sodium and chloride ions. In addition, decreased levels of lysozyme and potassium and phosphate ions are found. A change in the proteomic signature of a salivary peptide complex was noted in a boy who had clinical improvement of his Sjögren syndrome.[22] Although still considered experimental, these changes in salivary constituents are of unknown predictive value.
Sialography, Scintigraphy, and MRI
Sialography is a sensitive and specific radiographic technique for detecting sialectasis. However, sialography sensitivity has not been reported in the pediatric literature. These techniques are not commonly used at most pediatric centers; however, their use has been described by multiple investigators.[9, 23]
Technetium-99m (99m Tc) pertechnetate scintigraphy shows delayed uptake in Sjögren syndrome; often in correlation with pathologic changes.
Magnetic resonance imaging (MRI) visualizes the glandular parenchyma and aids in the evaluation of cystic or solid masses. In addition, the volumetric estimate of the gland size can be determined.
Salivary Gland Biopsy
The pathologic findings from biopsy are very useful in diagnosis and are often obtained in juvenile primary Sjögren syndrome workup. Because of its relative ease and lack of complications, labial minor salivary gland biopsy is preferred over parotid gland biopsy, which can result in facial nerve damage. However, minor salivary gland biopsy requires sufficient expertise to ensure adequacy of tissue collection.
In order to ensure that a representative sample has been obtained for histopathologic examination, harvesting 5-10 lobules of minor salivary glands is crucial. (See the image below.)
Biopsy of the minor salivary glands of the lower lip may be useful in the diagnosis of Sjögren syndrome. A 1.5- to 2-cm incision of normal-appearing mucosa allows for the harvesting of 5 or more salivary gland lobules. Histologic Findings
The characteristic histopathologic findings of the minor salivary glands include an inflammatory infiltrate adjacent to normal-appearing acinar structures. The inflammatory infiltrate consists of primarily lymphocytes and fewer plasma cells. Most of the infiltrating lymphocytes are activated CD4+ memory T lymphocytes. A focal periductal pattern is initially observed, with eventual confluence of the inflammatory infiltrate that replaces the acini. Periductal and perivascular hyaline deposits may be observed. (See the images below.)[6]
Low-power photomicrograph of a minor salivary gland lobule showing multiple lymphocytic foci that are replacing the acinar structures (hematoxylin-eosin, 40 X).
Intermediate-power photomicrograph demonstrating a chronic inflammatory aggregate of more than 50 lymphocytes and plasma cells with a periductal pattern. The inflammatory focus is adjacent to normal appearing acini (hematoxylin-eosin, 200 X).
High-power photomicrograph of the chronic inflammatory aggregate consists of lymphocytes and plasma cells around a ductal structure (hematoxylin-eosin, 400 X). Unlike the parotid gland lesions, epimyoepithelial islands are rarely observed in the lymphocytic background. The finding of more than 1 focus of 50 or more inflammatory cells within a 4-mm2 area of glandular tissue supports the diagnosis of Sjögren syndrome. The greater the number of foci, the greater the correlation with a disease diagnosis. However, a negative biopsy finding cannot completely exclude a diagnosis of Sjögren syndrome. Biopsy findings may also be used to rule out granulomatous (sarcoid) or amyloid lesions.
When the major glands are enlarged, a benign lymphoepithelial lesion (BLEL) may develop. The characteristic features include a dense, lymphocytic infiltrate that is associated with the destruction of salivary gland acini, while the ductal epithelium persists. Hyperplasia of the ductal epithelium and myoepithelial cells forms epimyoepithelial islands within the lymphoid tissues. Formation of germinal centers may be observed. In adult patients, a determination of monoclonality of the lymphocytic infiltrate by immunohistochemical or gene rearrangement studies may be necessary in order to exclude a low-grade B-cell lymphoma.
Screening Questions
In the questionnaire of adult salivary hypofunction, positive responses to all 4 of the following questions indicate major salivary gland hypofunction[24] : (1) Do you sip liquids to aid in swallowing dry foods? (2) Does your mouth feel dry when eating a meal? (3) Do you have difficulties swallowing any foods? (4) Does the amount of saliva in your mouth seem to be too little?
Less than 50% of pediatric patients report ocular symptoms, whereas older patients with Sjögren syndrome more frequently report them. Ocular screening questions include the following: (1) Have you had persistent dry eyes daily for more than 3 months? (2) Do you have recurrent sensation of sand or gravel in your eyes? (3) Do you use tear substitutes more than 3 times daily?
Fox RI. Sjogren's syndrome. Lancet. Jul 23-29 2005;366(9482):321-31. [Medline].
Jonsson R, Haga H-J, Gordon TP. Sjogren's syndrome. In: Koopman's Textbook of Arthritis and Allied Health Conditions. 14th ed. Philadelphia, PA: Lippincott, Williams, & Wilkins; 2001:1736-59.
Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, et al. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum. Mar 2004;50(3):882-91. [Medline].
Cassidy JT, Petty RE, Laxer RM. Overlap syndromes. In: Textbook of Pediatric Rheumatology. 5th ed. 2005:486-89.
Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. Mar 2005;64(3):347-54. [Medline]. [Full Text].
Ramos-Casals M, Font J. Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts. Rheumatology (Oxford). Nov 2005;44(11):1354-67. [Medline].
Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. Jun 28 2004;164(12):1275-84. [Medline].
Civilibal M, Canpolat N, Yurt A, et al. A child with primary Sjogren syndrome and a review of the literature. Clin Pediatr (Phila). Oct 2007;46(8):738-42. [Medline].
Cimaz R, Casadei A, Rose C, et al. Primary Sjogren syndrome in the paediatric age: a multicentre survey. Eur J Paediatr. 2003;162 (10):661-5. [Medline].
Anaya JM, Ogawa N, Talal N. Sjogren's syndrome in childhood. J Rheumatol. Jun 1995;22(6):1152-8. [Medline].
Nakamura Y, Wakamatsu E, Matsumoto I, et al. High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjogren syndrome. Ann Rheum Dis. Jan 2008;67(1):136-7. [Medline].
Arkfeld DG. The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int. Jan 2008;28(3):205-15. [Medline].
Reveille JD, Arnett FC. The immunogenetics of Sjogren's syndrome. Rheum Dis Clin North Am. Aug 1992;18(3):539-50. [Medline].
Singer NG, Tomanova-Soltys I, Lowe R. Sjogren's syndrome in childhood. Curr Rheumatol Rep. Apr 2008;10(2):147-55. [Medline].
DeGuzman M, Fishman MA, Lewis RA, et al. Chronic neurologic disease with visual, gait and bladder problems in a male teenager. J Pediatr. 1998;132:742-47. [Medline].
Kobayashi I, Furuta H, Tame A, et al. Complications of childhood Sjogren syndrome. Eur J Pediatr. Oct 1996;155(10):890-4. [Medline].
Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). Jul 2008;87(4):210-9. [Medline].
Houghton K, Malleson P, Cabral D, Petty R, Tucker L. Primary Sjogren's syndrome in children and adolescents: are proposed diagnostic criteria applicable?. J Rheumatol. Nov 2005;32(11):2225-32. [Medline].
Pessler F, Emery H, Dai L, Wu YM, Monash B, Cron RQ, et al. The spectrum of renal tubular acidosis in paediatric Sjögren syndrome. Rheumatology (Oxford). Jan 2006;45(1):85-91. [Medline].
Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. Jun 2002;61(6):554-8. [Medline]. [Full Text].
Bartunkova J, Sediva A, Vencovsky J, Tesar V. Primary Sjogren's syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Rheumatol. May-Jun 1999;17(3):381-6. [Medline].
Rigante D, Inzitari R, Carone M, et al. Correspondence between clinical improvement and proteomic changes of the salivary peptide complex in a child with primary Sjogren syndrome. Rheumatol Int. Jun 2008;28(8):801-6. [Medline].
Stiller M, Golder W, Döring E, Kliem K. Diagnostic value of sialography with both the conventional and digital subtraction techniques in children with primary and secondary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Nov 1999;88(5):620-7. [Medline].
Fox PC, Brennan M, Pillemer S, Radfar L, Yamano S, Baum BJ. Sjogren's syndrome: a model for dental care in the 21st century. J Am Dent Assoc. Jun 1998;129(6):719-28. [Medline].
van der Reijden WA, Vissink A, Veerman EC, Amerongen AV. Treatment of oral dryness related complaints (xerostomia) in Sjogren's syndrome. Ann Rheum Dis. Aug 1999;58(8):465-74. [Medline].
Suzuki K, Matsumoto M, Nakashima M, Takada K, Nakanishi T, Okada M, et al. Effect of cevimeline on salivary components in patients with Sjögren syndrome. Pharmacology. May 2005;74(2):100-5. [Medline].

